CBG (Cannabigerol): Properties, Therapeutic Uses, and Research

CBG (Cannabigerol) is a naturally occurring cannabinoid found in the Cannabis sativa plant. It originates from the precursor molecule cannabigerolic acid (CBGA), which forms the biochemical starting point for multiple other cannabinoids. Although CBG typically appears in low concentrations, it plays an important role in cannabinoid biosynthesis and is increasingly examined in scientific research. This article explains the fundamentals of CBG, its biochemical function, and the research questions that currently guide laboratory studies.

What is CBG?

Cannabigerol is a non-psychoactive plant molecule produced in small amounts within the resin-forming structures of the cannabis plant. Young plant tissue may contain comparatively higher proportions of CBGA, which then converts into other cannabinoids as the plant matures. Because many major cannabinoids originate from CBGA, CBG is often referred to as the “precursor cannabinoid”.

CBG interacts with the endocannabinoid system, which is involved in various physiological functions. The mechanisms of this interaction remain an active focus of research.

The way CBG appears together with other cannabinoids in a plant’s overall profile is often described using chemotypes, which group cultivars according to measurable cannabinoid ratios. Chemotypes provide a more objective, laboratory-based classification framework. A concise introduction is available in our article Cannabis chemotypes explained.

Biosynthesis: The role of CBGA

CBG itself appears only when a portion of CBGA does not convert into other cannabinoids. The basic biosynthetic chain includes:

• The plant produces CBGA (cannabigerolic acid) as a biochemical starting material.
• Specific enzymes convert CBGA into THCA, CBDA or CBCA, depending on genetic expression.
• A small fraction remains as CBGA and becomes CBG after decarboxylation.

This role as a biochemical branching point makes CBG scientifically important from a plant-metabolism perspective.

CBG vs. CBD: Scientific comparison

CBG and CBD are both non-psychoactive and derived from the same precursor, yet they differ in several scientific aspects:

• Origin: CBD forms when CBGA is enzymatically converted into CBDA, while CBG is the non-converted portion.
• Relative abundance: CBD is common in many cultivars, whereas CBG typically appears only in small amounts unless specifically bred for higher concentrations.
• Research intensity: CBD is extensively documented, while CBG has become a growing focus of new biochemical studies.

These distinctions are relevant for analytical chemistry, plant physiology, and breeding science.

Current research on CBG

Laboratory studies are examining several research questions related to CBG, including:

• How enzymatic pathways regulate the conversion of CBGA into other cannabinoids.
• Which genetic factors influence CBG formation during plant development.
• The molecular mechanisms by which CBG interacts with receptor systems.
• How selective breeding can increase CBG concentrations in specific cultivars.

Existing studies focus primarily on biochemical, genetic and plant-physiological contexts. Human-use interpretations are not part of these investigations and are intentionally excluded in compliance with regulatory guidelines.

Additional cannabinoid entries can be explored in the cannabinoid lexicon.

Botanical relevance of CBG

CBG plays a relevant role in cannabis plant biology due to:

• its position as the metabolic origin of major cannabinoids,
• its potential signalling role within plant-internal processes,
• its relevance as an analytical marker for growth stages,
• ongoing breeding developments aimed at higher CBG yields.

These aspects reflect botanical and biochemical relevance rather than consumer-oriented applications.

Further reading

For a broader overview of cannabinoids and their chemical classifications, visit the cannabinoid lexicon.